Minimal Residual Disease Evaluation Using 8-Color Flow Cytometry Predicts Risk of Relapse in High-Risk And/or Young Myeloma Patients Who Receive Bortezomib Consolidation after Frontline Tandem Transplantation
BLOOD(2018)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要